Eli Lilly And Company Price to Earnings Ratio (PE) Ratios, (LLY) Valuation Ranking and Trends, Fundamental Ratios

LLY Price to Earnings Ratio	Current	(Dec 31 2025)	(Sep 30 2025)	(Jun 30 2025)	(Mar 31 2025)
Diluted EPS 12 Trailing Months		IV. Quarter	III. Quarter	II. Quarter	I. Quarter
PE (TTM) Ratio	current 42.06	41.68	36.41	50.79	67.70
Diluted EPS TTM Y / Y Change	128.97 %	95.9 %	120.88 %	88.33 %	80.89 %
Diluted EPS Y / Y Change	169.93 %	51.23 %	480.37 %	91.77 %	23.39 %
Stock performance	to date 9.54 %	30.2 %	-1.66 %	-3.19 %	6.15 %

Price to earnings ratio Comment

Eli Lilly And Company's current Price to earnings ratio has increased due to shareprice growth of 9.54 %, from beginning of I. Quarter and despite eps increase of 169.93 %, to Pe of 42.06, from average Price to earnings ratio in IV. Quarter of 41.68.

Within Healthcare sector Eli Lilly And Company has the lowest Price to earnings ratio.

What is Price to Earnings Ratio?
What is Eli Lilly And Company Market Share?

Price to earnings ratio Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.